Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophageal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05594914
What this trial is testing

AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of University of South China 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT03110926
What this trial is testing

Induction Chemotherapy for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Carcinoma
University of Rochester 40
Testing effectiveness (Phase 2)Study completedNCT04984733
What this trial is testing

Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer

Who this might be right for
Adenocarcinoma - GEJCancer of Esophagus
University of Southampton 13
Large-scale testing (Phase 3)UnknownNCT01216527
What this trial is testing

Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer

Who this might be right for
Squamous Cell Esophageal Carcinoma
Sun Yat-sen University 430
Testing effectiveness (Phase 2)Looking for participantsNCT07205731
What this trial is testing

Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
University Hospital, Clermont-Ferrand 95
Testing effectiveness (Phase 2)UnknownNCT02812641
What this trial is testing

Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC

Who this might be right for
Stage III Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07554521
What this trial is testing

Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

Who this might be right for
Advanced Unresectable Gastric AdenocarcinomaEsophageal Squamous Cell CarcinomaAdvanced Gastroesophageal Adenocarcinoma
BeOne Medicines 30
Early research (Phase 1)Ended earlyNCT00732745
What this trial is testing

Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Case Comprehensive Cancer Center 9
Early research (Phase 1)Not Yet RecruitingNCT07726212
What this trial is testing

A First-in-human (FIH), Open-Label, Dose Escalation and Expansion Cohorts Study of MC002

Who this might be right for
Advanced Esophageal CancerAdvanced Lung Cancer
Hangzhou MacroLink Biopharmaceutical LLC 143
Testing effectiveness (Phase 2)Study completedNCT00016900
What this trial is testing

PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT05302011
What this trial is testing

Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital 28
Large-scale testing (Phase 3)UnknownNCT03002064
What this trial is testing

Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients

Who this might be right for
Esophagus CancerChemotherapy Effects
Sun Yat-sen University 358
Early research (Phase 1)Study completedNCT01495663
What this trial is testing

Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned

Who this might be right for
Cancer
Cellectar Biosciences, Inc. 12
Early research (Phase 1)Study completedNCT04713891
What this trial is testing

KF-0210 in Advanced Solid Tumors Patients

Who this might be right for
Advanced Solid TumorColorectal CancerLung Cancer+3 more
Keythera Pharmaceuticals (Australia) Pty Ltd 14
Large-scale testing (Phase 3)UnknownNCT03958890
What this trial is testing

A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Henlius Biotech 489
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Large-scale testing (Phase 3)Study completedNCT00416858
What this trial is testing

Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
Federation Francophone de Cancerologie Digestive 40
Testing effectiveness (Phase 2)Looking for participantsNCT06747585
What this trial is testing

Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Who this might be right for
Squamous Non-small-cell Lung CancerHead and Neck Squamous Cell CarcinomaCervical Squamous Cell Carcinoma+1 more
Alentis Therapeutics AG 170
Testing effectiveness (Phase 2)Ended earlyNCT03278626
What this trial is testing

Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
NYU Langone Health 12
Next Page